华海清, 秦叔逵. 康莱特治疗原发性肝癌的研究进展[J]. 中国肿瘤临床, 2012, 39(16): 1143-1147. DOI: 10.3969/j.issn.1000-8179.2012.16.002
引用本文: 华海清, 秦叔逵. 康莱特治疗原发性肝癌的研究进展[J]. 中国肿瘤临床, 2012, 39(16): 1143-1147. DOI: 10.3969/j.issn.1000-8179.2012.16.002
Haiqing HUA, Shukui QIN. Advancements in Kanglaite Treatment of Primary Liver Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(16): 1143-1147. DOI: 10.3969/j.issn.1000-8179.2012.16.002
Citation: Haiqing HUA, Shukui QIN. Advancements in Kanglaite Treatment of Primary Liver Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(16): 1143-1147. DOI: 10.3969/j.issn.1000-8179.2012.16.002

康莱特治疗原发性肝癌的研究进展

Advancements in Kanglaite Treatment of Primary Liver Cancer

  • 摘要: 薏苡仁是一种可以药食两用的传统中药, 主要抗肿瘤活性成分为薏苡仁甘油酯类, 其制剂康莱特注射液治疗原发性肝癌等恶性肿瘤效果明显, 且毒副反应轻微。本文就近年来康莱特注射液在原发性肝癌中的应用与研究进展作一综述。

     

    Abstract: Semen coicis is an edible type of traditional Chinese medicine. The coix ester and coix triglyceride are its main active ingredients with antitumor properties. Its therapeutic agent, referred to as Kanglaite, exhibits great effect towards treating malignant tumors, such as those of primary liver cancer, but has mild toxicity. This thesis mainly discusses the recent applications and research on Kanglaite in the treatment of primary liver cancer.

     

/

返回文章
返回